scroll to top
0

Mobile Menu

Header Layout

EBSCO Auth Banner

Let's find your institution. Click here.

Page title

Advanced Search Results For "HEADS of state"

1 - 10 of 21,824 results for
 "HEADS of state"
Results per page:

Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV-negative veterans.

Publication Type:Academic Journal

Source(s):Cancer [Cancer] 2022 Sep 15; Vol. 128 (18), pp. 3310-3318. Date of Electronic Publication: 2022 Jul 22.

Abstract:Background: Persons living with HIV/AIDS have a higher incidence of virus-related and tobacco/alcohol-related cancers. This study is the first to estimate the effect of HIV versus HIV-negative veterans on the risk of head and neck squamous cell carcino...

View details

Characteristics and outcomes associated with anxiety and depression in a head and neck cancer survivorship cohort.

Publication Type:Academic Journal

Source(s):American journal of otolaryngology [Am J Otolaryngol] 2022 May-Jun; Vol. 43 (3), pp. 103442. Date of Electronic Publication: 2022 Apr 05.

Abstract:Purpose: To assess the prevalence and predictors of mental health disorders (MDHs) among head and neck squamous cell carcinoma (HNSCC) survivors, and the association with health-related quality of life (HRQOL), pain, and survival outcomes.Materials and...

View details

Pembrolizumab with or without chemotherapy versus cetuximab plus chemotherapy to treat recurrent or metastatic head and neck squamous cell carcinoma: An updated KEYNOTE-048 based cost-effectiveness analysis.

Publication Type:Academic Journal

Source(s):Oral oncology [Oral Oncol] 2022 Jun; Vol. 129, pp. 105871. Date of Electronic Publication: 2022 Apr 25.

Abstract:Objectives: Recently, updated data from KEYNOTE-048 revealed that pembrolizumab with or without chemotherapy could improve progression-free survival (PFS)2 compared with cetuximab plus chemotherapy in recurrent or metastatic head and neck squamous cell...

View details

Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time.

Publication Type:Academic Journal

Source(s):Cancer [Cancer] 2022 May 01; Vol. 128 (9), pp. 1767-1774. Date of Electronic Publication: 2022 Feb 08.

Abstract:Background: Human papillomavirus (HPV) is responsible for a growing proportion of oropharyngeal squamous cell carcinomas (OPSCCs) among men and White individuals. Whether similar trends apply to women, non-Whites, and non-oropharyngeal squamous cell ca...

View details

Impact of Race and Insurance Status on Primary Treatment for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.

Publication Type:Academic Journal

Source(s):Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery [Otolaryngol Head Neck Surg] 2022 Jun; Vol. 166 (6), pp. 1062-1069. Date of Electronic Publication: 2021 Jul 13.

Abstract:Objective: To assess the impact of sociodemographic factors on primary treatment choice (surgery vs radiotherapy) in patients with human papillomavirus-associated (HPV+) oropharyngeal squamous cell carcinoma (OPSCC).Study Design: Retrospective analysis...

View details

Bereavement Practices Among Head and Neck Cancer Surgeons.

Publication Type:Academic Journal

Source(s):The Laryngoscope [Laryngoscope] 2022 Oct; Vol. 132 (10), pp. 1971-1975. Date of Electronic Publication: 2022 Jan 29.

Abstract:Objectives: Head and neck cancer surgeons frequently interact with dying patients with advanced disease and their families, but little is known about their bereavement practices after a patient's death. The aim of this study is to elucidate the frequen...

View details

Association Between Insurance Type and Outcomes of Reconstructive Head and Neck Cancer Surgery.

Publication Type:Academic Journal

Source(s):The Laryngoscope [Laryngoscope] 2022 Oct; Vol. 132 (10), pp. 1946-1952. Date of Electronic Publication: 2021 Nov 30.

Abstract:Objectives/hypothesis: Although the benefits of expanding health insurance coverage are clear, there are limited studies comparing the different types of insurance. This study aims to determine the association between insurance type and outcomes in pat...

View details

Consensus Quality Measures and Dose Constraints for Head and Neck Cancer with an emphasis on Oropharyngeal and Laryngeal Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel.

Publication Type:Academic Journal

Source(s):Practical radiation oncology [Pract Radiat Oncol] 2022 Sep-Oct; Vol. 12 (5), pp. 409-423. Date of Electronic Publication: 2022 Jun 04.

Abstract:Purpose: Safeguarding high-quality care using evidence-based radiation therapy for patients with head and neck cancer is crucial to improving oncologic outcomes, including survival and quality of life.Methods and Materials: The Veterans Administration ...

View details

Cost-effectiveness of pembrolizumab for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in the United States.

Publication Type:Academic Journal

Source(s):Journal of medical economics [J Med Econ] 2022 Jan-Dec; Vol. 25 (1), pp. 954-965.

Abstract:Aims: Pembrolizumab, as monotherapy in first-line recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) with a combined positive score (CPS) ≥1 and in combination with platinum and 5-fluorouracil (5-FU) in the overall R/M HNSCC po...

View details

Comment to: "Head and neck osteosarcomas: An analysis of treatment trends and survival outcomes in the United States (2004-2016)".

Publication Type:Editorial & Opinion

Source(s):Head & neck [Head Neck] 2021 Dec; Vol. 43 (12), pp. 4018-4019. Date of Electronic Publication: 2021 Sep 10.

View details

banner_970x250 (970x250)

sponsored